[Research Report] The joint pain injection market is expected to reach US$ 6,996.88 million by 2028 from US$ 3,667.45 million in 2020; it is estimated to grow at a CAGR of 8.5% during 2021–2028.
Joint pain injections provide faster relief from severe pain and reduce inflammation of joints. Several types of injections available in the market include corticosteroids injections, hyaluronic acid (HA) injections, platelet-rich plasma (PRP) injections, and placental tissue matrix (PTM) injections. The growth of the joint pain injection market is attributed to the factors such as high prevalence of musculoskeletal disorders and increasing number of sports injuries. However, high costs of joint repair therapies hinder the market growth
Lucrative Regions for Joint Pain Injection Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
High Prevalence of Musculoskeletal Disorders
Musculoskeletal disorders are medical conditions affecting muscles, bones, and joints of neck, shoulders, wrists, back, hips, legs, knees, and feet. These diseases include tendinitis, carpal tunnel syndrome, osteoarthritis, rheumatoid arthritis (RA), fibromyalgia, and bone fractures. As per the World Health Organization (WHO) factsheet updated in 2018, musculoskeletal conditions are the second-largest contributor to disability worldwide. According to the same, the prevalence and impact of musculoskeletal disorders is expected to rise with the increase in aging population and rise in the prevalence of risk factors of noncommunicable diseases (NCDs) worldwide. As per 2016 American Academy of Orthopedic Surgeons’ annual meeting data, ~1 in 2 adults is suffering from a musculoskeletal disorder in the US. Further, according to the Centers for Disease Control and Prevention (CDC), arthritis causes severe pain that affects millions of people in the US every year. Around one in four arthritis patients, i.e., ~15 million of total ~54 million patients, experiences severe arthritis-related joint pain.
Further, osteoarthritis (OA) is one of the most common joint disorders in the US, caused by the breakdown of joint cartilage between bones. It is also known as degenerative joint disease or “wear and tear” arthritis. As per the Centers for Disease Control and Prevention (CDC), more than 32.5 million adults in the US suffer from osteoarthritis. Similarly, as per the National Health Service (NHS), more than 10 million people in the UK have arthritis or other similar conditions that affect joints. As per the Bupa Health Insurance, osteoarthritis is the most common form of arthritis prevalent in the UK, it affects around the one-third of people aged 45 or more in the country, i.e., ~8.75 million people. Therefore, such high prevalence of musculoskeletal disorders in different countries is increasing the number of treatment procedures being carried out for the same, thereby driving the joint pain injection market growth.
Drugs-Based Insights
The joint pain injection market, by drug, is segmented into hyaluronic acid, corticosteroid, and others. The corticosteroid segment held the largest share of the market in 2020, and it is further anticipated to register the highest CAGR during the forecast period.
Joint pain injection Market, by Drug– 2020 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Joint Type-based Insights
Based on joint type, the joint pain injection market is segmented into knee, foot and ankle, shoulder and elbow, hips, and other applications. The knee segment held the largest market share in 2020 and is anticipated to register the highest CAGR in the market during the forecast period.
Distribution Channel-based Insights
Based on distribution channel, the joint pain injection market is segmented into retail pharmacies, hospitals pharmacies, and others. The wound care segment held the largest market share in 2020, and the bone grafts segment is estimated to register the highest CAGR in the market during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Joint Pain Injection Market: Strategic Insights
Market Size Value in US$ 3,667.45 Million in 2020 Market Size Value by US$ 6,996.88 Million by 2028 Growth rate CAGR of 8.5% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Joint Pain Injection Market: Strategic Insights
| Market Size Value in | US$ 3,667.45 Million in 2020 |
| Market Size Value by | US$ 6,996.88 Million by 2028 |
| Growth rate | CAGR of 8.5% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the joint pain injection market players focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally.
Joint Pain Injection Market – by Drug
- Hyaluronic Acid
- Corticosteroid
- Others
Joint Pain Injection Market – by Joint Type
- Knee
- Foot and Ankle
- Shoulder and Elbow
- Hip
- Others
Joint Pain Injection Market – by Distribution Channel
- Retail Pharmacies
- Hospitals Pharmacies
- Others
Joint Pain Injection Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Chugai Pharmaceutical Co., Ltd.
- Bioventus Inc.
- Fidia Pharma USA Inc.
- Flexion Therapeutics, Inc.
- SEIKAGAKU CORPORATION
- Ferring B.V.
- Sanofi
- Anika Therapeutics, Inc.
- Teva Pharmaceutical
- OrthogenRx, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Drug , Joint Type , and Distribution Channel
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Joint pain injections are medicinal fluids inserted in the patient’s body to get faster relief from severe pain. The joint pain injections are used to reduce inflammation in the joints. There are several types of injections available in the market which are corticosteroids injections, hyaluronic acid (HA) injections, platelet-rich plasma (PRP) injections and placental tissue matrix (PTM) injections.
The global joint pain injection market growth is mainly attributed to factors such the high prevalence of musculoskeletal disorders and increasing number of sports injuries. However, the high costs of joint repair therapies hinder the market growth.
The joint pain injection market majorly consists of the players such as Chugai Pharmaceutical Co., Ltd., Teva Pharmaceuticals, Bioventus Inc., Fidia Pharma USA Inc., Flexion Therapeutics, Inc., SEIKAGAKU CORPORATION, Ferring B.V., Sanofi, Anika Therapeutics, Inc., and OrthogenRx among others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Joint Pain Injection Market – By Drug
1.3.2 Global Joint Pain Injection Market – By Joint Type
1.3.3 Global Joint Pain Injection Market – By Distribution Channel
1.3.4 Global Joint Pain Injection Market – By Geography
2. Joint Pain Injection Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Joint Pain Injection – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Expert Opinions
5. Joint Pain Injection Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Musculoskeletal Disorders
5.1.2 Increasing Number of Sports Injuries
5.2 Market Restraints
5.2.1 High Costs of Joint Repair Therapies
5.3 Market Opportunities
5.3.1 Proliferation of Pharmaceutical Sector in Emerging Markets
5.4 Future Trends
5.4.1 Product Innovations
5.5 Impact Analysis
6. Joint Pain Injection Market – Global Analysis
6.1 Global Joint Pain Injection Market Revenue Forecast And Analysis
6.2 Global Joint Pain Injection Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Joint Pain Injection Market Analysis – By Drugs
7.1 Overview
7.2 Joint Pain Injection Market Revenue Share, by Drugs (2020 and 2028)
7.3 Hyaluronic Acid
7.3.1 Overview
7.3.2 Hyaluronic Acid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Corticosteroid
7.4.1 Overview
7.4.2 Corticosteroid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8. Joint Pain Injection Market Analysis – By Joint Type
8.1 Overview
8.2 Joint Pain Injection Market Revenue Share, by Joint Type (2020 and 2028)
8.3 Knee
8.3.1 Overview
8.3.2 Knee: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hip
8.4.1 Overview
8.4.2 Hip: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Foot and Ankle
8.5.1 Overview
8.5.2 Foot and Ankle: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Shoulder and Elbow
8.6.1 Overview
8.6.2 Shoulder and Elbow: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
9. Joint Pain Injection Market Analysis – By Distribution Channel
9.1 Overview
9.2 Joint Pain Injection Market Share, by Distribution Channel, 2020 and 2028, (%)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 Retail Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
10. Joint Pain Injection Market – Geographical Analysis
10.1 North America: Joint Pain Injection Market Revenue and Forecast to 2028
10.1.1 Overview
10.1.2 North America: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.3 North America: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.4 North America: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.5 North America: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.6 North America: Joint Pain Injection Market, by Country, 2020 & 2028 (%)
10.1.7 US: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.1 US: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.2 US: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.7.3 US: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.7.4 US: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.8 Canada: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.1 Canada: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.2 Canada: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.8.3 Canada: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.8.4 Canada: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.9 Mexico: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.9.1 Mexico: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.9.2 Mexico: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.9.3 Mexico: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.9.4 Mexico: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.2 Europe: Joint Pain Injection Market Revenue and Forecast to 2028
10.2.1 Overview
10.2.2 Europe: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.2.3 Europe: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.2.4 Europe: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.2.5 Europe: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.6 Europe: Joint Pain Injection Market, by Country, 2020 & 2028 (%)
10.2.7 Germany: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.2.7.1 Germany: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.2.7.2 Germany: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.2.7.3 Germany: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.2.7.4 Germany: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.8 UK: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.2.8.1 UK: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.2.8.2 UK: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.2.8.3 UK: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.2.8.4 UK: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.9 France: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.2.9.1 France: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.2.9.2 France: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.2.9.3 France: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.2.9.4 France: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.10 Italy: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.2.10.1 Italy: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.2.10.2 Italy: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.2.10.3 Italy: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.2.10.4 Italy: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.11 Spain: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.2.11.1 Spain: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.2.11.2 Spain: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.2.11.3 Spain: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.2.11.4 Spain: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.12 Rest of Europe: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.2.12.1 Rest of Europe: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.2.12.2 Rest of Europe: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.2.12.3 Rest of Europe: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.2.12.4 Rest of Europe: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.3 Asia Pacific: Joint Pain Injection Market Revenue and Forecast to 2028
10.3.1 Overview
10.3.2 Asia Pacific: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.3.3 Asia Pacific: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.3.4 Asia Pacific: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.3.5 Asia Pacific: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.3.6 Asia Pacific: Joint Pain Injection Market, by Country, 2020 & 2028 (%)
10.3.7 China: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.3.7.1 China: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.3.7.2 China: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.3.7.3 China: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.3.7.4 China: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.3.8 Japan: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.3.8.1 Japan: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.3.8.2 Japan: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.3.8.3 Japan: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.3.8.4 Japan: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.3.9 India: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.3.9.1 India: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.3.9.2 India: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.3.9.3 India: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.3.9.4 India: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.3.10 South Korea: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.3.10.1 South Korea: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.3.10.2 South Korea: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.3.10.3 South Korea: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.3.10.4 South Korea: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.3.11 Australia: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.3.11.1 Australia: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.3.11.2 Australia: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.3.11.3 Australia: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.3.11.4 Australia: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.3.12 Rest of Asia Pacific: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.3.12.1 Rest of Asia Pacific: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.3.12.2 Rest of Asia Pacific: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.3.12.3 Rest of Asia Pacific: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.3.12.4 Rest of Asia Pacific: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.4 Middle East & Africa: Joint Pain Injection Market Revenue and Forecast to 2028
10.4.1 Overview
10.4.2 Middle East and Africa: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.4.3 Middle East and Africa: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.4.4 Middle East and Africa: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.4.5 Middle East and Africa: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.4.6 Middle East and Africa: Joint Pain Injection Market, by Country, 2020 & 2028 (%)
10.4.7 South Africa: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.4.7.1 South Africa: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.4.7.2 South Africa: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.4.7.3 South Africa: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.4.7.4 South Africa: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.4.8 Saudi Arabia: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.4.8.1 Saudi Arabia: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.4.8.2 Saudi Arabia: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.4.8.3 Saudi Arabia: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.4.8.4 Saudi Arabia: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.4.9 UAE: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.4.9.1 UAE: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.4.9.2 UAE: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.4.9.3 UAE: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.4.9.4 UAE: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.4.10 Rest of Middle East and Africa: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.4.10.1 Rest of Middle East and Africa: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.4.10.2 Rest of Middle East and Africa: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.4.10.3 Rest of Middle East and Africa: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.4.10.4 Rest of Middle East and Africa: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.5 South and Central America: Joint Pain Injection Market Revenue and Forecast to 2028
10.5.1 South and Central America: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.5.2 South and Central America: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.5.3 South and Central America: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.5.4 South and Central America: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.5.5 South and Central America: Joint Pain Injection Market, by Country, 2020 & 2028 (%)
10.5.6 Brazil: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1 Brazil: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2 Brazil: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.5.6.3 Brazil: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.5.6.4 Brazil: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.5.7 Argentina: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.5.7.1 Argentina: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.5.7.2 Argentina: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.5.7.3 Argentina: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.5.7.4 Argentina: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.5.8 Rest of South and Central America: Joint Pain Injection Market- Revenue and Forecasts to 2027 (USD Million)
10.5.8.1 Rest of South and Central America: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.5.8.2 Rest of South and Central America: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.5.8.3 Rest of South and Central America: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.5.8.4 Rest of South and Central America: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on Global Joint Pain Injection Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Joint Pain Injection Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 2. Drugs
Table 3. North America Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 4. Joint Type
Table 5. North America Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 6. Distribution Channel
Table 7. US Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 8. Drugs
Table 9. US Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 10. Joint Type
Table 11. US Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 12. Distribution Channel
Table 13. Canada Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 14. Drugs
Table 15. Canada Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 16. Joint Type
Table 17. Canada Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 18. Distribution Channel
Table 19. Mexico Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 20. Drugs
Table 21. Mexico Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 22. Joint Type
Table 23. Mexico Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 24. Distribution Channel
Table 25. Europe Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 26. Drugs
Table 27. Europe Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 28. Joint Type
Table 29. Europe Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 30. Distribution Channel
Table 31. Germany Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 32. Drugs
Table 33. Germany Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 34. Joint Type
Table 35. Germany Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 36. Distribution Channel
Table 37. UK Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 38. Drugs
Table 39. UK Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 40. Joint Type
Table 41. UK Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 42. Distribution Channel
Table 43. France Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 44. Drugs
Table 45. France Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 46. Joint Type
Table 47. France Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 48. Distribution Channel
Table 49. Italy Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 50. Drugs
Table 51. Italy Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 52. Joint Type
Table 53. Italy Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 54. Distribution Channel
Table 55. Spain Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 56. Drugs
Table 57. Spain Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 58. Joint Type
Table 59. Spain Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 60. Distribution Channel
Table 61. Rest of Europe Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 62. Drugs
Table 63. Rest of Europe Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 64. Joint Type
Table 65. Rest of Europe Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 66. Distribution Channel
Table 67. Asia Pacific Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 68. Drugs
Table 69. Asia Pacific Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 70. Joint Type
Table 71. Asia Pacific Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Distribution Channel
Table 72. China Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 73. Drugs
Table 74. China Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 75. Joint Type
Table 76. China Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 77. Distribution Channel
Table 78. Japan Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 79. Drugs
Table 80. Japan Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 81. Joint Type
Table 82. Japan Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 83. Distribution Channel
Table 84. India Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 85. Drugs
Table 86. India Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 87. Joint Type
Table 88. India Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Distribution Channel
Table 89. South Korea Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 90. Drugs
Table 91. South Korea Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 92. Joint Type
Table 93. South Korea Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Distribution Channel
Table 94. Australia Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 95. Drugs
Table 96. Australia Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 97. Joint Type
Table 98. Australia Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 99. Distribution Channel
Table 100. Rest of Asia Pacific Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 101. Drugs
Table 102. Rest of Asia Pacific Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 103. Joint Type
Table 104. Rest of Asia Pacific Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 105. Distribution Channel
Table 106. Middle East and Africa Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 107. Drugs
Table 108. Middle East and Africa Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 109. Joint Type
Table 110. Middle East and Africa Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 111. Distribution Channel
Table 112. South Africa Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 113. Drugs
Table 114. South Africa Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 115. Joint Type
Table 116. South Africa Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 117. Distribution Channel
Table 118. Saudi Arabia Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 119. Drugs
Table 120. Saudi Arabia Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 121. Joint Type
Table 122. Saudi Arabia Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 123. Distribution Channel
Table 124. UAE Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 125. Drugs
Table 126. UAE Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Joint Type
Table 127. UAE Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 128. Distribution Channel
Table 129. Rest of Middle East and Africa Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 130. Drugs
Table 131. Rest of Middle East and Africa Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 132. Joint Type
Table 133. Rest of Middle East and Africa Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 134. Distribution Channel
Table 135. South and Central America Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Drugs
Table 136. South and Central America Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Joint Type
Table 137. South and Central America Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Distribution Channel
Table 138. Brazil Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 139. Drugs
Table 140. Brazil Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 141. Joint Type
Table 142. Brazil Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 143. Distribution Channel
Table 144. Argentina Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Drugs
Table 145. Argentina Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Joint Type
Table 146. Argentina Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Distribution Channel
Table 147. Rest of South and Central America Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 148. Drugs
Table 149. Rest of South and Central America Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 150. Joint Type
Table 151. Rest of South and Central America Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 152. Distribution Channel
Table 153. Organic Developments Done By Companies
Table 154. Inorganic Developments Done By Companies
Table 155. Glossary of Terms, Joint Pain Injection Market
LIST OF FIGURES
Figure 1. Joint Pain Injection Market Segmentation
Figure 2. Joint Pain Injection Market Segmentation, By Region
Figure 3. Joint Pain Injection Market Overview
Figure 4. Knee Joint Type Segment Held Largest Share of Joint Pain Injection Market
Figure 5. North America to Show Significant Growth During Forecast Period
Figure 6. Joint Pain Injection Market, by Geography (US$ Million)
Figure 7. Global Joint Pain Injection Market – Leading Country Markets (US$ Million)
Figure 8. Global Joint Pain Injection Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 1. Number of Sports Injuries in US, 2019
Figure 2. Joint Pain Injection Market Impact Analysis of Driver and Restraints
Figure 3. Global Joint Pain Injection Market – Revenue Forecast And Analysis – 2020- 2028
Figure 4. Global Joint Pain Injection Market – By Geography Forecast and Analysis – 2019- 2027
Figure 5. Market Positioning Of Key Players In Global Joint Pain Injection Market
Figure 6. Joint Pain Injection Market Revenue Share, by Drugs (2020 and 2028)
Figure 7. Hyaluronic Acid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 8. Corticosteroid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 9. Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Joint Pain Injection Market Revenue Share, by Joint Type (2020 and 2028)
Figure 11. Knee: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Hip: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Foot and Ankle: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Shoulder and Elbow: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Other: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Joint Pain Injection Market Share, by Distribution Channel, 2020 and 2028 (%)
Figure 17. Hospital Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Retail Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. North America: Joint Pain Injection Market, by Key Country – Revenue (2020) (USD Million)
Figure 21. North America Joint Pain Injection Market Revenue and Forecast to 2028 (USD Million)
Figure 22. North America: Joint Pain Injection Market, by Country, 2020 & 2028 (%)
Figure 23. US: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. Canada: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. Mexico: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Europe: Joint Pain Injection Market, by Key Country – Revenue (2020) (USD Million)
Figure 27. Europe Joint Pain Injection Market Revenue and Forecast to 2028 (USD Million)
Figure 28. Europe: Joint Pain Injection Market, by Country, 2020 & 2028 (%)
Figure 29. Germany: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. UK: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. France: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Italy: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Spain: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Rest of Europe: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Asia Pacific: Joint Pain Injection Market, by Key Country – Revenue (2020) (USD Million)
Figure 36. Asia Pacific Joint Pain Injection Market Revenue and Forecast to 2028 (USD Million)
Figure 37. Asia Pacific: Joint Pain Injection Market, by Country, 2020 & 2028 (%)
Figure 38. China: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Japan: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. India: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. South Korea: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. Australia: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 43. Rest of Asia Pacific: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 44. Middle East and Africa: Joint Pain Injection Market, by Key Country – Revenue (2020) (USD Million)
Figure 45. Middle East and Africa Joint Pain Injection Market Revenue and Forecast to 2028 (USD Million)
Figure 46. Middle East and Africa: Joint Pain Injection Market, by Country, 2020 & 2028 (%)
Figure 47. South Africa: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. Saudi Arabia: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. UAE: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 50. Rest of Middle East and Africa: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 51. South and Central America: Joint Pain Injection Market, by Key Country – Revenue (2020) (USD Million)
Figure 52. South and Central America Joint Pain Injection Market Revenue and Forecast to 2028 (USD Million)
Figure 53. South and Central America: Joint Pain Injection Market, by Country, 2020 & 2028 (%)
Figure 54. Brazil: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 55. Argentina: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 56. Rest of South and Central America: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 57. Impact of COVID-19 Pandemic in North American Country Markets
Figure 58. Impact of COVID-19 Pandemic in Europe Country Markets
Figure 59. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 60. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 61. Impact of COVID-19 Pandemic in Rest of World Country Markets
Figure 62. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Joint Pain Injection Market
- Chugai Pharmaceutical Co., Ltd.
- Bioventus Inc.
- Fidia Pharma USA Inc.
- Flexion Therapeutics, Inc.
- SEIKAGAKU CORPORATION
- Ferring B.V.
- Sanofi
- Anika Therapeutics, Inc.
- Teva Pharmaceutical
- OrthogenRx, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Joint Pain Injection Market
Apr 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)